Clinical Trial Update: Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure [Phase 2]

View source ↗

Summary

An open-label Phase 2 study evaluating Perhexiline in patients with hypertrophic cardiomyopathy and moderate-to-severe heart failure was terminated; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertrophic Cardiomyopathy

Drugs mentioned

• Perhexiline (perhexiline)

Snippet

Sponsor: Heart Metabolics Limited | Conditions: Cardiomyopathy, Hypertrophic, Cardiomyopathy, Hypertrophic, Familial | Phase 2 | Status: TERMINATED | Results posted: 2017-08-31